ClinicalTrials.gg
Not yet recruitingNCT07210827Updated Oct 7, 2025

Deviated Nasal Septum Effect on Maxillary Sinus Volumes and Development of Maxillary Sinusitis by CT

An observational study in Deviated Nasal Septum and Maxillary Sinusitis, sponsored by Assiut University. Not yet recruiting. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2025-10-07.

Sponsored by Assiut University · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
120
Ages
18 Years to 75 Years
Sex
All
01

Study summary

By using CT of the nose and paranasal sinuses, we'll study the effect of nasal septum deviation on maxillary sinus volumes, assess the association between the severity and type of nasal septum deviation and the occurrence of maxillary sinusitis and compare the maxillary sinus volume on the deviated side with that of the contralateral side.

02

Conditions studied

  • Deviated Nasal Septum and Maxillary Sinusitis
03

In context

Lead sponsor

Assiut University is the lead sponsor of 5,094 studies on the registry; 2,187 are open to participants now.

Of its 14 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Patients presented to outpatient clinic at Assiut University hospital complaining of nasal symptoms like nasal obstruction, rhinorrhea ,headache, and recurrent sinusitis.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Age ≥18 years.
  2. Availability of high-resolution CT scans of paranasal Sinuses (axial, coronal, sagittal views).
  3. Adequate imaging quality allowing sinus volumetry and septal deviation measurement.
  4. Anatomical landmarks visible: Crista galli, hard palate, choanae, uncinate process/OMC region clearly identifiable to permit NSD measurement and sinus segmentation.

Exclusion criteria

Exclusion Criteria:

  1. Age \< 18 years.
  2. Previous sinonasal or maxillofacial surgery.
  3. History of facial trauma or fractures affecting the nasal septum or sinus walls.
  4. Sinonasal tumors, polyps, or large cysts.
  5. Congenital craniofacial anomalies (e.g., cleft palate).
  6. head and neck syndromes.
  7. Cases with systemic diseases affecting growth and development.

    -

05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
120 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. CT based comparison in cases with deviated nasal septum

    Time frame: Baseline

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Razavi M, Shams N, Pirasteh SMA. Determining the effects of deviated nasal septum on maxillary sinus volume using cone-beam computed tomography. Immunopathol Persa. 2023;9(1):e34427
  • Elahi MM, Frenkiel S, Fageeh N. Paraseptal structural changes and chronic sinus disease in relation to the deviated septum. J Otolaryngol. 1997 Aug;26(4):236-40. PubMed 9263892 ↗
  • Serifoglu I, Oz II, Damar M, Buyukuysal MC, Tosun A, Tokgoz O. Relationship between the degree and direction of nasal septum deviation and nasal bone morphology. Head Face Med. 2017 Feb 28;13(1):3. doi: 10.1186/s13005-017-0136-2. PubMed 28245851 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Oct 2025; primary completion for Oct 2026, 12 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 30, 2025
First posted
Oct 7, 2025
StartEst.
Oct 1, 2025
Primary completionEst.
Oct 2026
CompletionEst.
Oct 2026
Last update
Oct 7, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 7, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07210827
Lead sponsor
Assiut University
Responsible party
Rana Emad Ali (Ent resident, Assiut University) — Principal investigator
First posted
Oct 7, 2025
Start date
Oct 1, 2025 (estimated)
Primary completion
Oct 2026 (estimated)
Completion
Oct 2026 (estimated)
Last update
Oct 7, 2025

Study contacts

Rana Emad Ali
Contact
Rana.17289805@med.aun.edu.eg
20+1026232442
Shymaa Ibrahim
Contact
Shimaa.ibrahem@aun.edu.eg
20+1285876066
Ahmed Abdelaleem
study chair · Professor at ENT department,Assiut University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion